Page last updated: 2024-12-07

irganox 3114

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Irganox 3114 is a hindered phenol antioxidant commonly used to stabilize polymers against degradation caused by oxidation. It is typically incorporated during the polymerization process or added to the final product. The compound is a white to light yellow powder that is soluble in organic solvents but insoluble in water. Its effectiveness as an antioxidant is attributed to its ability to scavenge free radicals that are generated during the oxidation process. This scavenging action helps to prevent the formation of chain reactions that lead to polymer degradation. The study of Irganox 3114 is important in fields like polymer science, materials science, and packaging. It is researched to understand its efficacy in different polymer systems, to optimize its use for different applications, and to explore its potential for improving the durability and longevity of products. Irganox 3114 is a commercially important compound due to its widespread use in various industries, such as plastics, rubber, and adhesives. Research efforts are ongoing to synthesize Irganox 3114 efficiently and develop new antioxidant compounds with improved properties.'

Irganox 3114: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93115
SCHEMBL ID31375
MeSH IDM0544061

Synonyms (47)

Synonym
tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate
c48h69n3o6
1,3,5-triazine-2,4,6(1h,3h,5h)-trione, 1,3,5-tris((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)-
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1h,3h,5h)-trione
s-triazine-2,4,6(1h,3h,5h)-trione, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-
einecs 248-597-9
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazinane-2,4,6-trione
1,3,5-triazine-2,4,6(1h,3h,5h)-trione, 1,3,5-tris[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]-
27676-62-6
FT-0652727
1,3,5-tris[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3,5-triazinane-2,4,6-trione
1,3,5-tris[(3,5-ditert-butyl-4-hydroxy-phenyl)methyl]-1,3,5-triazinane-2,4,6-trione;1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazinane-2,4,6-trione
A819153
680v3mp8yt ,
ec 248-597-9
unii-680v3mp8yt
tris(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate
AKOS015895750
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)(1,3,5)triazin-2,4,6-trione
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazinetrione
plastic additive 6 [usp-rs]
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate
1,3,5-tris(4-hydroxy-3,5-di-tert-butylbenzyl)cyanuric acid
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazine-2,4,6(1h,3h,5h)-trione
1,3,5-tri(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate
plastic additive 6
T3653
1,3,5-tris(3,5-di-t-butyl-4-hydroxylbenzyl)-1,3,5-triazine-2,4,6(1h, 3h,5h)-trione
tris-(3,5-di-tert-butyl-4-hydroxybenzyl)-isocyanurate
irganox 3114
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazine-2,4,6(1h,3h, 5h)-trione
VNQNXQYZMPJLQX-UHFFFAOYSA-N ,
SCHEMBL31375
tris-(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate
tris(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanur
W-107098
DTXSID0027935
mfcd00134700
plastic additive 6, united states pharmacopeia (usp) reference standard
plastic additive 13, european pharmacopoeia (ep) reference standard
1,3,5-tris-(3,5-di-t-butyl-4-hydroxybenzyl)isocyanurate
AS-15297
isocyanuric acid tris(3,5-di-tert-butyl-4-hydroxybenzyl) ester
SB73676
Q27264187
CS-W011393
antioxidant3114
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.29 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index41.66 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]